AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company's products include Rosnilimab, a selective pathogenic T cell ...
Q2 2026
Aug 5, 2026
Q1 2026
May 12, 2026
FY 2025
Mar 3, 2026
Q4 2025
Q3 2025
Nov 4, 2025